Bioequivalence Study Between Two Oral Formulations of Gemfibrozil Tablets
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
healthy men or women 18 years of age or older
weight within +/- 20% for height and body frame
willing to participate and sign a copy of the informed consent form
recent history of drug or alcohol addiction or abuse
pregnant or lactating women
history of allergic response to gemfibrozil
use of tobacco products
evidence of a clinically significant disorder or whose laboratory results were deemed to be clinically significant
receipt of any drugs as part of a research study within 28 days prior to study dosing